These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9234950)

  • 1. Chimeric papillomavirus-like particles.
    Müller M; Zhou J; Reed TD; Rittmüller C; Burger A; Gabelsberger J; Braspenning J; Gissmann L
    Virology; 1997 Jul; 234(1):93-111. PubMed ID: 9234950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.
    Wakabayashi MT; Da Silva DM; Potkul RK; Kast WM
    Intervirology; 2002; 45(4-6):300-7. PubMed ID: 12566713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsidating artificial human papillomavirus-16 mE7 protein in human papillomavirus-6b L1/L2 virus like particles.
    Xu YF; Wang QY; Zhang HT; Han YH; Song GX; Xu XM
    Chin Med J (Engl); 2007 Mar; 120(6):503-8. PubMed ID: 17439745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.
    Schäfer K; Müller M; Faath S; Henn A; Osen W; Zentgraf H; Benner A; Gissmann L; Jochmus I
    Int J Cancer; 1999 Jun; 81(6):881-8. PubMed ID: 10362134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol.
    Freyschmidt EJ; Alonso A; Hartmann G; Gissmann L
    Antivir Ther; 2004 Aug; 9(4):479-89. PubMed ID: 15456078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.
    Zhang H; Huang Y; Fayad R; Spear GT; Qiao L
    J Virol; 2004 Aug; 78(15):8342-8. PubMed ID: 15254206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.
    Da Silva DM; Pastrana DV; Schiller JT; Kast WM
    Virology; 2001 Nov; 290(2):350-60. PubMed ID: 11883199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.
    Greenstone HL; Nieland JD; de Visser KE; De Bruijn ML; Kirnbauer R; Roden RB; Lowy DR; Kast WM; Schiller JT
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1800-5. PubMed ID: 9465097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
    Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
    J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.
    Mossadegh N; Gissmann L; Müller M; Zentgraf H; Alonso A; Tomakidi P
    Virology; 2004 Aug; 326(1):57-66. PubMed ID: 15262495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
    Heino P; Dillner J; Schwartz S
    Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.
    Rudolf MP; Fausch SC; Da Silva DM; Kast WM
    J Immunol; 2001 May; 166(10):5917-24. PubMed ID: 11342606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly.
    Li M; Cripe TP; Estes PA; Lyon MK; Rose RC; Garcea RL
    J Virol; 1997 Apr; 71(4):2988-95. PubMed ID: 9060658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particles and E1-E4 protein expressed from the human papillomavirus type 11 bicistronic E1-E4-L1 transcript.
    Brown DR; Pratt L; Bryan JT; Fife KH; Jansen K
    Virology; 1996 Aug; 222(1):43-50. PubMed ID: 8806486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein.
    Ghim SJ; Rector A; Delius H; Sundberg JP; Jenson AB; Van Ranst M
    Biochem Biophys Res Commun; 2004 Nov; 324(3):1108-15. PubMed ID: 15485669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies towards the potential of poliovirus as a vector for the expression of HPV 16 virus-like-particles.
    van Kuppeveld FJ; de Jong A; Dijkman HB; Andino R; Melchers WJ
    FEMS Immunol Med Microbiol; 2002 Nov; 34(3):201-8. PubMed ID: 12423772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between papillomavirus L1 and L2 capsid proteins.
    Finnen RL; Erickson KD; Chen XS; Garcea RL
    J Virol; 2003 Apr; 77(8):4818-26. PubMed ID: 12663788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and neutralization of pseudovirions of human papillomavirus type 33.
    Unckell F; Streeck RE; Sapp M
    J Virol; 1997 Apr; 71(4):2934-9. PubMed ID: 9060652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes.
    Liu WJ; Liu XS; Zhao KN; Leggatt GR; Frazer IH
    Virology; 2000 Aug; 273(2):374-82. PubMed ID: 10915608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.